Clinical Trial Update: Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 trial in Korean patients with seasonal allergic rhinitis evaluating safety, tolerability, and efficacy of bilastine 20 mg. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Bilastine (bilastine)

Snippet

Sponsor: Yuhan Corporation | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED